| 000 | 01714 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516020823.0 | ||
| 264 | 0 | _c20110210 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1538-3601 | ||
| 024 | 7 |
_a10.1001/archophthalmol.2010.321 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMichaelides, Michel | |
| 245 | 0 | 0 |
_aRetinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. _h[electronic resource] |
| 260 |
_bArchives of ophthalmology (Chicago, Ill. : 1960) _cJan 2011 |
||
| 300 |
_a30-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aChloroquine _xadverse effects |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aElectroretinography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxychloroquine _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRetina _xdrug effects |
| 650 | 0 | 4 |
_aRetinal Diseases _xchemically induced |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 |
_aVision Disorders _xchemically induced |
| 650 | 0 | 4 | _aVisual Field Tests |
| 650 | 0 | 4 | _aVisual Fields |
| 700 | 1 | _aStover, Niamh B | |
| 700 | 1 | _aFrancis, Peter J | |
| 700 | 1 | _aWeleber, Richard G | |
| 773 | 0 |
_tArchives of ophthalmology (Chicago, Ill. : 1960) _gvol. 129 _gno. 1 _gp. 30-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archophthalmol.2010.321 _zAvailable from publisher's website |
| 999 |
_c20504948 _d20504948 |
||